When treatment of the advanced cancer, the hormone acceptor (an esurogen acceptor, a progesterone acceptor) of the tumor including the supporting medical treatment for early cancer are positive, the hormone therapy is used, but the side effect occurs.
A hormone medicine is combined with such an acceptor and, during a hormone therapy surgical operation, hinders estrogen from arriving at it and destroys a cancer cell and restrains a recurrence.
There is tamoxifen in a representative medicine restraining estrogenic action.
In the case of the endometrial cancer (endometrium cancer), frequency of the endometrial cancer increases by the dosage for the long term of the medicine that S Toda diol (an ovarian follicle hormone secreted by the ovary) action is strong as having mentioned above.
But it is thought female sex hormone replacement therapy as the therapeutic method that is most effective for a change in various ways of the body situation by the sudden fall of the female sex hormone that prevention is enabled by combination of the progestin (a corpus luteum hormone resemblance material) (this combination therapy has onset deterrent effect of the endometrial cancer), but this treatment lets you continue it to how old, or there are a lot of points had for acceptance of the aging of the natural phenomenon future problem.
